Greater Noida, Delhi NCR – Amber LifeSciences, a trailblazer in the pharmaceutical and healthcare industry, proudly participated in CPHI & PMEC India 2025, held from November 25th to 27th at the India Expo Centre, Greater Noida. As one of the most anticipated events in the global pharma calendar, CPHI India brought together over 50,000 visitors, 2,000+ exhibiting companies, and representatives from 120+ countries, solidifying its position as the heart of the pharmaceutical industry.
Under the theme “Turning Connections into Endless Opportunity,” the event served as a dynamic platform for Amber LifeSciences to showcase its innovative solutions and strengthen its presence in the global pharma community. With 120,000+ square meters of exhibition space, the expo was a hub of inspiration, collaboration, and cutting-edge advancements, aligning perfectly with Amber LifeSciences’ mission to drive innovation and deliver excellence.
Amber LifeSciences’ booth was a focal point of attraction, featuring interactive displays and live demonstrations of its state-of-the-art technologies. The company highlighted its expertise in Contract Development and Manufacturing Organization (CDMO) services, emphasizing its ability to address the evolving needs of the industry. From advanced drug development to sustainable manufacturing practices, Amber LifeSciences demonstrated its commitment to shaping the future of pharma.
The event also provided an unparalleled opportunity for networking and collaboration.
Amber LifeSciences engaged with industry leaders, potential clients, and partners, exploring new avenues for growth and innovation. The company’s representatives participated in key discussions on topics such as “Innovation in Pharma: Driving Change Through Technology” and “Global Supply Chain Resilience,” sharing insights on overcoming challenges and leveraging opportunities in the ever-evolving pharmaceutical landscape.
One of the standout features of CPHI India 2024 was its focus on digital and in-person engagement solutions, ensuring year-round connectivity for the global pharma community. Amber LifeSciences embraced this initiative, showcasing its digital capabilities and commitment to staying connected with stakeholders worldwide.
Reflecting on the event, a spokesperson for Amber LifeSciences said, “CPHI India 2024 was an incredible platform to connect, collaborate, and innovate. We are inspired by the endless opportunities this event has unlocked and remain dedicated to driving positive change in the pharmaceutical industry.”
As the curtains closed on the expo, Amber LifeSciences left an indelible mark, reaffirming its position as a trusted partner in the global pharma community. The company looks forward to building on the connections made and continuing its journey toward a healthier, more innovative future.
